1. Home
  2. BIO vs MTZ Comparison

BIO vs MTZ Comparison

Compare BIO & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$283.93

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$387.78

Market Cap

24.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
MTZ
Founded
1952
1929
Country
United States
United States
Employees
7450
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
24.9B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
BIO
MTZ
Price
$283.93
$387.78
Analyst Decision
Buy
Strong Buy
Analyst Count
4
18
Target Price
$339.75
$339.47
AVG Volume (30 Days)
407.4K
940.9K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.12
EPS
N/A
0.77
Revenue
N/A
$14,299,171,000.00
Revenue This Year
$2.74
$20.38
Revenue Next Year
$3.20
$10.18
P/E Ratio
$9.72
$497.90
Revenue Growth
N/A
16.22
52 Week Low
$211.43
$152.43
52 Week High
$343.12
$441.43

Technical Indicators

Market Signals
Indicator
BIO
MTZ
Relative Strength Index (RSI) 59.24 48.70
Support Level $262.08 $369.04
Resistance Level $288.48 $441.43
Average True Range (ATR) 9.78 17.73
MACD 3.26 -6.63
Stochastic Oscillator 96.00 26.79

Price Performance

Historical Comparison
BIO
MTZ

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

Share on Social Networks: